Imugene Price Target Raised 47% to A$0.25/Share by Bell Potter, page-68

Wow TB, it looks like you had extra Weetabix this morning!

Three great posts.

Although people mention fmg, but so many promising stocks have failed - tis, acl, ftt etc.

But you are right, and as I said I am a very very strong believer in IMU.

One other big positive and major point of difference with IMU is their scientific and advisory boards. I don't think I have ever seen such a who's who of cancer researchers.

People like the head of ESMO, and imu is the only board he sits on!

So the really smart people are choosing to stand with IMU.

I must admit I'm a cautious investor. Investing in the Aussie biotech sector hasn't always been rosey over the last 20 years or so. And taking profits has been the key to my ability to stay in the game so long, especially with the credit crunch, 911, dotcom collapse, banking crisis, covid etc etc...

But I'm still holding many IMU shares until the end.

Cheers.